Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Janux Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +5 vs. Q2 2022
- Shares held
- 29.6M
- +647.2K (+2.2%) vs. Q2 2022
- Total value
- $400.3M
- +$47.3M (+13.4%) vs. Q2 2022
- New holders
- 5
- 17 more added
- Sold out
- 0
- 13 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,670,644 | $117.4M | 2.50% | 00.0% | Unchanged |
| FMR LLC | 6,247,392 | $84.6M | 0.01% | +421,688+7.2% | Added |
| OrbiMed Advisors LLC | 2,836,386 | $38.4M | 0.76% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 1,960,044 | $26.5M | 0.02% | −167,753−7.9% | Reduced |
| Citadel Advisors LLC | 1,853,216 | $25.1M | 0.03% | −2160.0% | Reduced |
| BVF Inc | 1,470,334 | $19.9M | 0.82% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 1,421,319 | $19.2M | 0.57% | 00.0% | Unchanged |
| BlackRock Inc. | 1,250,348 | $16.9M | 0.00% | +41,994+3.5% | Added |
| Vanguard Group Inc | 760,474 | $10.3M | 0.00% | +110,834+17.1% | Added |
| 5AM Venture Management, LLC | 446,266 | $6.04M | 1.16% | 00.0% | Unchanged |
| Woodline Partners LP | 400,181 | $5.42M | 0.08% | +113,798+39.7% | Added |
| Adage Capital Partners GP, L.L.C. | 400,000 | $5.42M | 0.01% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 360,414 | $4.88M | 1.14% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 334,521 | $4.53M | 0.00% | +50,901+17.9% | Added |
| State Street Corp | 264,207 | $3.58M | 0.00% | +185+0.1% | Added |
| Morgan Stanley | 141,480 | $1.92M | 0.00% | +113,747+410.2% | Added |
| Northern Trust Corp | 136,364 | $1.85M | 0.00% | +3,207+2.4% | Added |
| Cerity Partners LLC | 105,933 | $1.43M | 0.02% | −45,000−29.8% | Reduced |
| JPMorgan Chase & Co | 105,053 | $1.42M | 0.00% | +1,575+1.5% | Added |
| Nuveen Asset Management, LLC | 72,877 | $987.0K | 0.00% | −1,996−2.7% | Reduced |
| Bank of New York Mellon Corp | 50,093 | $679.0K | 0.00% | +7,707+18.2% | Added |
| DekaBank Deutsche Girozentrale | 49,500 | $669.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 46,563 | $631.0K | 0.00% | +4,053+9.5% | Added |
| Parkwood LLC | 33,352 | $452.0K | 0.10% | −398−1.2% | Reduced |
| Rhumbline Advisers | 25,580 | $346.0K | 0.00% | +1,678+7.0% | Added |
| Bank of America Corp | 15,157 | $206.0K | 0.00% | −10,361−40.6% | Reduced |
| Goldman Sachs Group Inc | 14,047 | $190.0K | 0.00% | −1,817−11.5% | Reduced |
| Chicago Partners Investment Group LLC | 10,621 | $181.0K | 0.01% | +10,621 | New |
| New York State Common Retirement Fund | 13,259 | $180.0K | 0.00% | +5,246+65.5% | Added |
| Balyasny Asset Management LLC | 12,182 | $165.0K | 0.00% | +12,182 | New |
| MetLife Investment Management | 10,614 | $143.7K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 8,099 | $110.0K | 0.00% | −1,143−12.4% | Reduced |
| American International Group, Inc. | 8,147 | $110.0K | 0.00% | +115+1.4% | Added |
| BNP Paribas Arbitrage, SA | 7,638 | $103.4K | 0.00% | +7,638 | New |
| California State Teachers Retirement System | 6,774 | $92.0K | 0.00% | −564−7.7% | Reduced |
| Amalgamated Bank | 2,182 | $30.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,742 | $24.0K | 0.00% | +302+21.0% | Added |
| Metropolitan Life Insurance Co | 1,382 | $18.7K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,155 | $16.0K | 0.00% | −809−41.2% | Reduced |
| Citigroup Inc | 985 | $13.0K | 0.00% | −1,166−54.2% | Reduced |
| Ameritas Investment Partners, Inc. | 1,014 | $13.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 728 | $10.0K | 0.00% | −132−15.3% | Reduced |
| China Universal Asset Management Co., Ltd. | 390 | $5.00K | 0.00% | +390 | New |
| Royal Bank of Canada | 234 | $3.00K | 0.00% | +137+141.2% | Added |
| Daiwa Securities Group Inc. | 121 | $2.00K | 0.00% | 00.0% | Unchanged |
| Crewe Advisors LLC | 115 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 45 | $1.00K | 0.00% | −29,595−99.8% | Reduced |
| Credit Suisse AG | 94 | $1.00K | 0.00% | +77+452.9% | Added |
| Capital Advisors, Ltd. LLC | 90 | $1.00K | 0.00% | +90 | New |